Doctors should discuss financial concerns of cancer patients (DukeHealth.org)
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Cancer studies often lack necessary rigor to answer key questions (DukeHealth.org)
Apr. 29, 2013
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Immortality gene mutation identifies brain tumors and other cancers (DukeHealth.org)
Mar. 18, 2013
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
Less Invasive Treatment is Associated with Improved Survival in Early Stage Breast Cancer (DukeHealth.org)
Jan. 28, 2013
Patients with early stage breast cancer who are treated with lumpectomy plus radiation have a better chance of survival compared with those who undergo mastectomy, according to Duke Medicine research.
Sickle Cells Show Potential to Attack Aggressive Cancer Tumors (DukeHealth.org)
Jan. 9, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Experts Identify Critical Genes Mutated in Stomach Cancer (DukeHealth.org)
Apr. 9, 2012
An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Centre of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide.
Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs (DukeHealth.org)
Mar. 18, 2012
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Discovery Could Reduce Chemotherapy's Side Effects (DukeHealth.org)
Mar. 11, 2012
A team of researchers at Duke University has determined the structure of a key molecule that can carry chemotherapy and anti-viral drugs into cells, which could help to create more effective drugs with fewer effects to healthy tissue.
Dedication of the Duke Cancer Center Ushers in New Era of Patient Care (DukeHealth.org)
Feb. 23, 2012
A major achievement in patient-centered cancer care was celebrated with the dedication of the Duke Cancer Center, the new facility that will be the hub for Duke's preeminent cancer care, clinical research, and education.
Belk Inc. Donates $1 Million to Establish The Belk Boutique at the Duke Cancer Center (DukeHealth.org)
Feb. 15, 2012
Belk, Inc., has announced a $1 million gift over five years to establish a boutique in the new Duke Cancer Center that will provide fashions, cosmetics, and other items selected for the specific needs of cancer patients.
Contact Us
|
Careers
|
Make a Gift
|
Site Map
